AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Xitoglip-M 50mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Exito Pharma

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Xitoglip-M 50mg/500mg Tablet

Combiflex-D 50mg/500mg tablets contain a dual-action formula managing elevated blood glucose in patients with type 2 diabetes. This helps mitigate severe diabetic complications like renal impairment and vision loss, potentially lowering heart attack and stroke risk. Combiflex-D 50mg/500mg tablets can be used as monotherapy or in conjunction with other antidiabetic agents. Optimal efficacy is achieved with a balanced diet and regular physical activity. Dosage is personalized based on individual health status, glucose levels, and concurrent medications. Consuming the medication with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefits; discontinuation should only occur under physician guidance. Adherence to the prescribed diet and exercise plan is crucial for effective diabetes management, as lifestyle choices significantly influence blood sugar control. Commonly reported side effects include diarrhea, nausea, vomiting, indigestion, headache, and pharyngitis. Hypoglycemia is a potential adverse effect, particularly when used with insulin or sulfonylureas; therefore, understanding hypoglycemia recognition and management is essential. This medication isn't universally appropriate. Prior to initiating treatment, inform your doctor of any history of kidney, liver, or heart disease, pancreatic issues, or significant alcohol consumption. Pregnant or lactating individuals should seek medical counsel before use. Interactions with other medications are possible; therefore, disclose all medications to your physician to ensure treatment safety. Alcohol consumption should be minimized due to its potential to lower blood glucose. Your physician will monitor renal function and blood glucose levels throughout treatment.

Uses of Xitoglip-M 50mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Xitoglip-M 50mg/500mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the 50mg/500mg Xitoglip-M tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.

Common Side effects of Xitoglip-M 50mg/500mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Xitoglip-M 50mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet; do not chew, crush, or fracture it. Administer Xitoglip-M 50mg/500mg tablets with a meal.

How Xitoglip-M 50mg/500mg Tablet works:

Xitoglip-M 50mg/500mg tablets combine sitagliptin and metformin to manage blood glucose. Sitagliptin boosts insulin production from the pancreas, enhances insulin effectiveness, and diminishes hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and improves insulin sensitivity. This dual action optimizes blood sugar regulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Xitoglip-M 50mg/500mg tablets is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Xitoglip-M 50mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Xitoglip-M 50mg/500mg tablets while breastfeeding is likely inadvisable. Preliminary human evidence indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Xitoglip-M 50mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Xitoglip-M 50mg/500mg tablets. Physician consultation is advised. Regular monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

The use of Xitoglip-M 50mg/500mg tablets is likely contraindicated for individuals with hepatic impairment and should be omitted. Seek medical advice.

What if you forget to take Xitoglip-M 50mg/500mg Tablet :

Should you forget a Xitoglip-M 50mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Xitoglip-M 50mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Xitoglip-M 50mg/500mg Tablet

Xitoglip-M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged use of Xitoglip-M 50mg/500mg tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as numbness, tingling in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Xitoglip-M 50mg/500mg tablets may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Xitoglip-M 50mg/500mg Tablets are contraindicated in patients with allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Xitoglip-M 50mg/500mg tablets with alcohol is unsafe and may raise your risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and ensure it remains inaccessible to children, pets, and others.
Lactic acidosis, a serious medical emergency (also known as MALA, or Metformin-associated lactic acidosis), is a potential side effect of Xitoglip-M 50mg/500mg tablets. This occurs due to excess lactic acid in the bloodstream and is rare, but avoided in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Xitoglip-M immediately and seek medical attention.
Xitoglip-M 50mg/500mg tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Xitoglip-M 50mg/500mg tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Xitoglip-M 50mg/500mg Tablets are contraindicated in patients with allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Xitoglip-M 50mg/500mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Lactic acidosis, a serious medical emergency (also known as MALA, or Metformin-associated lactic acidosis), is a potential side effect of Xitoglip-M 50mg/500mg tablets. This occurs due to elevated blood lactic acid levels. Because it's rare, metformin use is avoided in individuals with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms can include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Xitoglip-M and seek immediate medical attention.
Prolonged use of Xitoglip-M 50mg/500mg tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and urinary issues), cognitive changes, and balance problems (ataxia). To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container as directed on the label or packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Xitoglip-M 50mg/500mg tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Xitoglip-M 50mg/500mg tablets may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis may occur. Prolonged use can also result in vitamin B12 deficiency.
Xitoglip-M 50mg/500mg Tablets are contraindicated in patients with allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Xitoglip-M 50mg/500mg tablets with alcohol is unsafe and may raise your risk of lactic acidosis.
Lactic acidosis, a serious medical emergency (also known as MALA, or Metformin-associated lactic acidosis), is a potential side effect of Xitoglip-M 50mg/500mg Tablets. This occurs due to excessive lactic acid buildup in the blood. Because it's rare but potentially life-threatening, Xitoglip-M is avoided in patients with kidney disease, the elderly, and heavy alcohol users. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Xitoglip-M and seek immediate medical attention.
Prolonged use of Xitoglip-M 50mg/500mg tablets can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may cause anemia, neurological issues such as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication. Keep out of reach of children, pets, and others.
Xitoglip-M 50mg/500mg Tab...
107